From Conception to Delivery: A Pharmacist-Focused Review of Recent Advances in Prenatal Supplements

NOVEMBER 19, 2012
Mary M. Bridgeman, PharmD, BCPS, CGP, and Kavitha S. Dalal, PharmD

This activity is supported by an educational grant from vitaMedMD, LLC.

From Conception to Delivery: A Pharmacist-Focused Review of Recent Advances in Prenatal Supplements

Mary M. Bridgeman, PharmD, BCPS, CGP
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Clinical Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey

Kavitha S. Dalal, PharmD
Pharmacy Field Manager
Clinical Adjunct Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey


Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty: Mary M. Bridgeman, PharmD, BCPS, CGP, and Kavitha S. Dalal, PharmD

Pharmacy Times Office of Continuing Professional Education (PTOCPE) Planning Staff: Judy V. Lum, MPA, and Elena Beyzarov, PharmD

Pharmacy Times Editorial Staff: Jennifer Whartenby and David Allikas


Educational Objectives

Upon completion of this educational activity, participants should be able to:

  1. Review updated recommended daily allowances for vitamins, minerals, and other nutrients in pregnancy.
  2. Examine the similarities and differences of available OTC and prescription prenatal supplements.
  3. Discuss prenatal supplement requirements for special patient populations.
  4. Explore the pharmacist's role in educating patients and prescribers on the differences between available prenatal supplements and counseling on the importance of patient adherence.

Target audience: Pharmacists
Type of activity: Knowledge
Release date: November 5, 2012
Expiration date: November 5, 2014
Estimated time to complete activity: 2 hours
Fee: This lesson is free online

Click here to view this activity.



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.